Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with Carcinoma
International Journal of Molecular Sciences · 11.09.2024 · 25 (18) · 9841
DOI: 10.3390/ijms25189841 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.09.2024. Verfasst von Ludmilla Thomé Domingos Chinen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hcor Research Institute, São Paulo 04004-030, Brazil. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplastic Cells, Circulating, Polyploidy, Giant Cells. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP.
Abstract (Originalsprache)
Polyploid Giant Cancer Cells (PGCCs) have been recognized as tumor cells that are resistant to anticancer therapies. However, it remains unclear whether their presence in the bloodstream can be consistently detected and utilized as a clinical marker to guide therapeutic anticancer regimens. To address these questions, we conducted a retrospective study involving 228 patients diagnosed with six different types of carcinomas (colon, gastric, NSCLC, breast, anal canal, kidney), with the majority of them (70%) being non-metastatic. Employing a highly sensitive liquid biopsy approach, ISET®, and cytopathological readout, we isolated and detected circulating PGCCs in the patients’ blood samples. PGCCs were identified in 46 (20.18%) out of 228 patients, including in 14.47% of 152 non-metastatic and 29.85% of 67 metastatic cases. Patients were subsequently monitored for a mean follow up period of 44.74 months (95%CI: 33.39–55.79 months). Remarkably, the presence of circulating PGCCs emerged as a statistically significant indicator of poor overall survival. Our findings suggest that circulating PGCCs hold promise as a reliable prognostic indicator. They underscore the importance of further extensive investigations into the role of circulating PGCCs as a prognostic marker and the development of anti-PGCC therapeutic strategies to improve cancer management and patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hcor Research Institute, São Paulo 04004-030, Brazil.
- Hospital Amaral Carvalho, Jaú 17210-080, Brazil.
- Department of Farmacology, Federal University of São Paulo (UNIFESP), São Paulo 04044-020, Brazil.
- Department of Computational Biomedicine, Biostatistics Shared Resource, Cedars-Sinai Cancer Center, Los Angeles, CA 90069, USA.
- Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo 01509-900, Brazil.
- Rarecells Faculté de Médecine Necker, 160 Rue de Vaugirard, 75015 Paris, France.
ORCID-Profile: Jacqueline Aparecida Torres, Vinicius Fernando Calsavara, Patrizia Paterlini-Brechot
Förderung
- FAPESP
Zitieren
APA
Chinen, L. T. D., Torres, J. A., Calsavara, V. F., Brito, A. B. C., Silva, V. S. E., Novello, R. G. S., Fernandes, T. C., Decina, A., Dachez, R., & Paterlini-Brechot, P. (2024). Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with Carcinoma. International Journal of Molecular Sciences, 25(18), 9841. https://doi.org/10.3390/ijms25189841
Vancouver
Chinen LTD, Torres JA, Calsavara VF, Brito ABC, Silva VSE, Novello RGS, et al. Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with Carcinoma. International Journal of Molecular Sciences. 2024;25(18):9841. doi:10.3390/ijms25189841
BibTeX
@article{Chinen2024,
author = {Chinen, Ludmilla Thomé Domingos and Torres, Jacqueline Aparecida and Calsavara, Vinicius Fernando and Brito, Angelo Borsarelli Carvalho and Silva, Virgílio Sousa E and Novello, Roberto Gabriel Santiago and Fernandes, Thaissa Carvalho and Decina, Alessandra and Dachez, Roger and Paterlini-Brechot, Patrizia},
title = {Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {9841},
doi = {10.3390/ijms25189841}
}
EUVIMED